Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
217.28Price to Book
VS
Market
Sector
Industry
History
$ 6.49Close
$ 5.06 - $ 8.78 52-Week Range
Ticker Information
Ticker
LFCRCompany Name
LIFECORE BIOMEDICAL INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQLIFECORE BIOMEDICAL INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LFCR - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 1.34M | $ 290.29M | 217.28 |
| 3/31/2025 | $ 2.23M | $ 252.14M | 113.12 |
| 12/31/2024 | $ 15.45M | $ 246.59M | 15.96 |
| 9/30/2024 | $ -3.94M | $ 166.23M | 0 |
| 6/30/2024 | $ 11.31M | $ 195.89M | 17.31 |
| 3/31/2024 | $ 17.69M | $ 154.66M | 8.74 |
| 6/30/2023 | $ -4.23M | $ 153.04M | 0 |
| 3/31/2023 | $ 34.21M | $ 247.13M | 7.22 |
| 12/31/2022 | $ 74.17M | $ 154.93M | 2.09 |
| 9/30/2022 | $ 96.9M | $ 243.87M | 2.52 |
Key Performance Insights, Last 5 Years
- LIFECORE BIOMEDICAL INC's latest trailing twelve months (TTM) P/B stands at 1.52.
- Over the past 5 years, LIFECORE BIOMEDICAL INC's average P/B has been 26.48.
- The median P/B for LIFECORE BIOMEDICAL INC during this period was 2.52
- LIFECORE BIOMEDICAL INC reached its highest P/B over the past 5 years at 217.28.
- The lowest P/B recorded by LIFECORE BIOMEDICAL INC in the same timeframe 1.43
LIFECORE BIOMEDICAL INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for LIFECORE BIOMEDICAL INC is calculated as follows: Market Cap [ $ 316.69M ] / Equity [ $ 208.94M ]
(=) P/B [ 1.52 ] LFCR - Price to Book, Last 5 years
1.43
Minimum
Sep 30, 2021
217.28
Maximum
Jun 30, 2025
26.48
Average
2.52
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |